cyproterone acetate has been researched along with Dwarfism, Pituitary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, T | 1 |
| Hashimoto, N; Hibi, I; Kagawa, J; Shizume, K; Tanae, A; Tanaka, T; Yoshizawa, A | 1 |
1 review(s) available for cyproterone acetate and Dwarfism, Pituitary
| Article | Year |
|---|---|
[Did growth hormone-deficient children grow up to normal adult height by growth hormone treatment?].
Topics: Adolescent; Body Height; Bone Development; Cyproterone Acetate; Dwarfism, Pituitary; Female; Growth Hormone; Humans; Male; Medroxyprogesterone Acetate; Puberty | 1992 |
1 other study(ies) available for cyproterone acetate and Dwarfism, Pituitary
| Article | Year |
|---|---|
The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children.
Topics: Adolescent; Body Height; Child; Cyproterone; Cyproterone Acetate; Dwarfism, Pituitary; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Gonadotropins; Growth Hormone; Humans; Male; Medroxyprogesterone; Ovary; Puberty; Testis | 1989 |